Within the next week, Highmark and UPMC are supposed to settle their differences over cancer reimbursement payments and rates on other services. A judge set the deadline back in May, and the two sides have been meeting privately over the summer, trying to see if they can reach some accord.

They are now awaiting the ruling of two arbitration panels brought in to mediate, and the implications could be significant — perhaps setting a course for whether the two Pittsburgh health giants will ever be able to agree on network and payment matters, or if every minor tiff will end up before an arbitration panel.

“From the public’s perspective, it’s gotten to the point where they can’t agree on anything, and this arbitration process by itself is probably an indication of how bad things are,” said Stephen Foreman, a health care administration professor at Robert Morris University.

Kristen Brown, prothonotary for Commonwealth Court, this week said the court’s President Judge Dan Pellegrini last received a progress report Sept. 1 that both sides were “engaged in highly productive negotiations.” Neither side is commenting on the particulars of those negotiations.

Advertise with us

“Our understanding is that they have gone through two arbitrations, and they’re awaiting the decision of the arbitration panels,” said James A. Donahue III, executive deputy attorney general for the state in Attorney General Kathleen Kane’s office.

The two arbitrations were necessary because UPMC and Highmark have separate disputes over rates the insurer pays — one related to cancer treatments and the second to rates for other treatments provided for Highmark members such as emergency and trauma care.

One needs to look no further than the need for two arbitration panels to illustrate that this has not been an easy dispute to resolve.

While one issue before one of the three-member arbitration panels addresses a variety of rates, from emergency care to reimbursement for care provided at outlying hospitals, the other is very specific to cancer payments.

In April 2014, Highmark officials said they would stop paying what they considered UPMC “markups” for cancer care after it designated care at physician offices as higher-paying hospital outpatient centers.

Advertise with us

UPMC maintains the payment schedule is legal and Highmark is contractually obligated to pay it. UPMC financial statements have put the contested amount at $170 million.

UPMC officials maintain that withholding the cancer payments represents a “unilateral material change” to consent decrees established last year that negated provisions meant to protect vulnerable populations.

Because of that, the region’s largest health system in April said Highmark’s 182,000 Medicare Advantage members would be considered out of network starting in 2016.

State officials including the attorney general’s office intervened, filing a complaint in Commonwealth Court that UPMC was in violation of the consent decrees. Judge Pellegrini ruled in the state’s favor, and UPMC has appealed to the state Supreme Court. Arguments on that appeal will be held Oct. 6 in Pittsburgh.

Whether an arbitration panel ruling on cancer payments affects the Supreme Court’s view of the dispute about Highmark’s Medicare Advantage members is unknown. Mr. Foreman is not optimistic that any court ruling will end the fighting entirely.

Advertise with us

“If it rules for UPMC unilaterally, that tells UPMC they can get away with this kind of stuff. And if they rule for Highmark, then Highmark is incentivized to dig their heels in,” he said.

“We can’t afford to have one of them win. The town needs them both. That’s what’s so difficult about this stuff getting into the legal system.”

Steve Twedt: stwedt@post-gazette.com or 412-263-1963.